跳至主要内容
临床试验/DRKS00012534
DRKS00012534进行中(未招募)未知

Effect of a probiotic combination on anti-Helicobacter pylori treatment related adverse effects in children - a multicenter double blind RCT - HeliP Study

Klinikum der Universität München, Campus Innenstadt0 个研究点目标入组 33 人开始时间: 2017年6月27日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
5 Years 至 18 Years(—)
性别
All

入选标准

  • (a) Male or female patients aged between 5 - 18 years.
  • (b) Minimal body weight of 15 kg.
  • (c) H. pylori infection confirmed by positive culture and results of susceptibility testing for clarithromycin and metronidazole.
  • (d) No previous therapy for H. pylori infection.
  • (e) Screening diary completed with = 6/7 days.
  • (f) Written informed consent by parents/care giver and patients (6-11 years and 12-17 years).

排除标准

  • (a) Significant acute or chronic gastrointestinal or other disease interfering with assessment of symptoms.
  • (b) Known allergies to used antibiotics, proton pump inhibitors or probiotics.
  • (c) Having received treatment with antibiotics or bismuth compounds during the previous 30 days.
  • (d) Having received proton pump inhibitors during the previous two weeks.
  • (e) Having received probiotic therapy during the previous 14 days.
  • (f) Being infected with a strain resistant to clarithromycin and metronidazole (double resistant).
  • (g) Severe acquired or primary immunodeficiency.
  • (h) Diarrhea as defined in the study protocol for at least 2 days documented on the screening diary.

研究者

发起方
Klinikum der Universität München, Campus Innenstadt

相似试验